BMS Pharm Korea
- A10 - Antidiabéticos
- BYDUREON powder and solvent for suspension for injection 2 mg
- BYETTA solution for injection 10 µg/2.4 ml
- BYETTA solution for injection 5 µg/1.2 ml
- FORXIGA film-coated tablet 10 mg
- FORXIGA film-coated tablet 5 mg
- KOMBIGLYZE XR prolonged-release tablet 1 000 mg+2.5 mg
- KOMBIGLYZE XR prolonged-release tablet 1 000 mg+5 mg
- KOMBIGLYZE XR prolonged-release tablet 500 mg+5 mg
- ONGLYZA film-coated tablet 2.5 mg
- ONGLYZA film-coated tablet 5 mg
- B01 - Agentes antitrombóticos
- ELIQUIS film-coated tablet 2.5 mg
- ELIQUIS film-coated tablet 5 mg
- H02 - Corticosteroides para uso sistémico
- FLORINEF tablet 0.1 mg
- J02 - Antimicóticos de uso sistémico
- FUNGIZONE powder for solution for infusion 50 mg
- J05 - Antivirales de uso sistémico
- BARACLUDE film-coated tablet 0.5 mg
- BARACLUDE film-coated tablet 1 mg
- BARACLUDE oral solution 0.05 mg/ml
- DAKLINZA film-coated tablet 60 mg
- EVOTAZ film-coated tablet 300 mg+150 mg
- REYATAZ capsule, hard 150 mg
- REYATAZ capsule, hard 200 mg
- SUNVEPRA capsule, soft 100 mg
- VIDEX EC gastro-resistant capsule, hard 200 mg
- VIDEX EC SR gastro-resistant capsule, hard 125 mg
- VIDEX EC SR gastro-resistant capsule, hard 250 mg
- VIDEX EC SR gastro-resistant capsule, hard 400 mg
- L01 - Antineoplásicos
- SPRYCEL film-coated tablet 100 mg
- SPRYCEL film-coated tablet 20 mg
- SPRYCEL film-coated tablet 50 mg
- SPRYCEL film-coated tablet 70 mg
- SPRYCEL film-coated tablet 80 mg
- TAXOL concentrate for solution for infusion 30 mg/5 ml
- YERVOY concentrate for solution for infusion 200 mg/40 ml
- YERVOY concentrate for solution for infusion 50 mg/10 ml
- L04 - Inmunosupresores
- ORENCIA powder for solution for infusion 250 mg
- ORENCIA PREFILLED SYRINGE solution for injection 125 mg/1 ml